Literature DB >> 11838655

Reversible restrictive cardiomyopathy due to light-chain deposition disease.

Motoyuki Nakamura1, Mamoru Satoh, Shugo Kowada, Hidetoshi Satoh, Atsushi Tashiro, Fumitoshi Sato, Tomoyuki Masuda, Katsuhiko Hiramori.   

Abstract

Systemic light-chain deposition due to plasma cell dyscrasias manifests as a form of restrictive cardiomyopathy with diastolic ventricular dysfunction. Although these manifestations are likely to be cardiac amyloidosis, whether these pathological conditions are reversible after treatment of the underlying plasma cell disorders is unknown. To our knowledge, we describe the first patient with cardiac light-chain deposition due to multiple myeloma in whom echocardiographic and biochemical factors of cardiac function were ameliorated dramatically after remission of this disorder. We emphasize that restrictive cardiomyopathy due to light-chain deposition may be reversible and have a relatively better prognosis after remission of plasma cell dyscrasias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11838655     DOI: 10.4065/77.2.193

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

1.  Discrimination between pericardial disease and myocardial disease using tissue Doppler imaging in a patient with right-sided heart failure and multiple myeloma.

Authors:  K G van Houwelingen; J J Bax; J W Jukema; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2003-02       Impact factor: 2.357

2.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

3.  Role of imaging in the detection of reversible cardiomyopathy.

Authors:  Jae-Hyeong Park; Deborah H Kwon; Randall C Starling; Thomas H Marwick
Journal:  J Cardiovasc Ultrasound       Date:  2013-06-26

4.  A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma.

Authors:  Meera Mohan; Murat Gokden; Neriman Gokden; Carolina Schinke
Journal:  Am J Case Rep       Date:  2016-03-18

5.  A case of cardiac dysfunction associated with monoclonal gammopathy of undetermined significance.

Authors:  Suk-Tae Jang; Il-Suk Sohn; Eun-Sun Jin; Jin-Man Cho; Chong-Jin Kim; Sung-Jig Lim
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

6.  Light chain deposition disease presenting as paroxysmal atrial fibrillation: a case report.

Authors:  Fabio Fabbian; Nevio Stabellini; Sergio Sartori; Paola Tombesi; Arrigo Aleotti; Maurizio Bergami; Simona Uggeri; Adriana Galdi; Christian Molino; Luigi Catizone
Journal:  J Med Case Rep       Date:  2007-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.